Seizure risk in brain tumor patients with conversion to generic levetiracetam.

J Neurooncol

University of Texas Health Science Center, Houston School of Nursing, 6901 Bertner Ave, Houston, TX 77030, USA.

Published: May 2010

Breakthrough seizure activity has been reported with conversion from brand name to generic anticonvulsants. This has prompted several organizations to support physician notification of generic substitution and patient consent. Recently, a generic formulation of levetiracetam has become available. Risk of seizures with generic levetiracetam has yet to be reported. Literature was reviewed regarding risk of generic substitution. Four cases of seizure activity in primary brain tumor patients after conversion from Keppra to generic levetiracetam are reported. In all cases, there was no evidence of tumor growth or concurrent illness that would increase the risk of seizures. In three cases, the patients have remained seizure free with conversion back to Keppra. The final patient required an increased dose of levetiracetam. As has been described with generic substitution of other anticonvulsants, patients switched to generic levetiracetam may be at risk for breakthrough seizure activity.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-009-0066-3DOI Listing

Publication Analysis

Top Keywords

generic levetiracetam
16
seizure activity
12
generic substitution
12
generic
9
brain tumor
8
tumor patients
8
patients conversion
8
breakthrough seizure
8
levetiracetam risk
8
risk seizures
8

Similar Publications

Anti-seizure medications (ASMs) are specific types of anticonvulsants used to treat epileptic seizures. However, several studies have shown an association between ASMs and an increased risk of hematological disorders, such as thrombocytopenia, aplastic anemia, and platelet function disorders leading to prolonged bleeding times. This review explores the existing literature on this topic, investigating a wide variety of ASMs, ranging from first-generation medications to newer ones.

View Article and Find Full Text PDF
Article Synopsis
  • CHDED (Congenital Heart Defect and Ectodermal Dysplasia) is an autosomal dominant disorder linked to the PRKD1 gene, characterized by heart issues and ectodermal abnormalities.
  • A case study of a 9-month-old Japanese girl demonstrated brain calcifications and seizures, revealing a new pathogenic variant in the PRKD1 gene.
  • It is suggested that PRKD1, along with ITGB2 and JAM2, may interact through a common signaling pathway leading to brain calcifications, providing insight into the genetic basis of this disorder.
View Article and Find Full Text PDF

Herein, we present a case of idiopathic generalized epilepsy (IGE) manifesting as de novo late-onset absence status epilepticus (ASE) following mild coronavirus disease 2019 (COVID-19). A woman in her 40s presented with persistent 3-5.5 Hz generalized spike-wave complexes (SWCs) on electroencephalography (EEG).

View Article and Find Full Text PDF

Temporal lobe epilepsy (TLE) can cause different types of memory impairments. Here, we report a case of immediate improvement of memory impairment following antiepileptic drug (AED) treatment in a patient with TLE with amygdala enlargement (TLE-AE), who rapidly developed recurrence. The patient was a man in his 60s whose family members complained of his amnesia.

View Article and Find Full Text PDF

New Onset Absence Status Epilepticus in Pregnancy: A Case Report.

J Epilepsy Res

December 2024

Department of Neurology, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey.

Absence status epilepticus may occur in persons diagnosed with idiopathic/genetic epilepsy as well as in adult and elderly patients. Despite being a rare phenomenon, pregnant women with no previous history of epileptic seizures may be presented with new onset status epilepticus. In this report, we describe the case of a 22-year-old pregnant female with no prior history of seizures.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!